Metraipolis › archive › dc_d69f2e39945e

Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy — Europe PMC PMID:41645394

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41645394
DOI
10.1002/cncr.70291
License (as archived)
solo-consultazione
Archived
2026-11-06T08:17:49.027Z
SHA-256 of the archived text
fa1bc680777d5cfeb6315c55a567d1c095ceef85a1175444e1ba9bd556066419
Stable URL of this page
https://metraipolis.com/documento/dc_d69f2e39945e

How to cite

Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy — Europe PMC PMID:41645394 — Europe PMC (en), https://europepmc.org/article/MED/41645394 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d69f2e39945e (Metraipolis archive dc_d69f2e39945e, sha256 fa1bc680777d5cfeb6315c55a567d1c095ceef85a1175444e1ba9bd556066419)
BibTeX
@misc{dcd69f2e39945e,
  title = {Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy — Europe PMC PMID:41645394},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41645394},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d69f2e39945e; sha256 fa1bc680777d5cfeb6315c55a567d1c095ceef85a1175444e1ba9bd556066419},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645394. Agents can read the archived copy with the MCP tool read_document.